Oncternal Therapeutics Inc
Biotechnology
Healthcare
ONCT
49.43 M shares
NASDAQ US
traded
16 Aug 2022
listed
yes
open
1.23
52 week high
6.64
high
1.40
52 week low
1.33
low
1.21
growth
-69.77 %
previous Close
1.43
P/E ratio
market cap
53.38 M
div yield
0
usd
Jun 2022
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
-15.00 %
eps surprise
0.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top